A variety of short interfering RNAs (siRNAs), as well as miRNAs have been tested for anti-cancer effects in HCC cells in vitro, targeting the major components of the EGFR/PI3K/AKT/mTOR signaling pathway. This evidence concerns the gene AKT1 and hepatocellular carcinoma.